Cargando…
Consensus on the treatment of vitiligo – Brazilian Society of Dermatology()()
BACKGROUND: Vitiligo is a muco-cutaneous, autoimmune, localized, or disseminated disease, which manifests through hypochromic or achromic macules, with loss in quality of life. The prevalence of vitiligo in Brazil was determined to be 0.54%. There is no on-label medication for its treatment. To date...
Autores principales: | Dellatorre, Gerson, Antelo, Daniela Alves Pereira, Bedrikow, Roberta Buense, Cestari, Tania Ferreira, Follador, Ivonise, Ramos, Daniel Gontijo, Silva de Castro, Caio Cesar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772607/ https://www.ncbi.nlm.nih.gov/pubmed/33153826 http://dx.doi.org/10.1016/j.abd.2020.05.007 |
Ejemplares similares
-
How persistent stigma and discrimination keep people with visible skin diseases out of jobs: vitiligo in Brazil today
por: Silveira, Luísa Polo, et al.
Publicado: (2023) -
Experimental approaches to assess melanocytes mosaicism in segmental vitiligo()
por: Dellatorre, Gerson, et al.
Publicado: (2023) -
Consensus on the diagnostic and therapeutic management of chronic
spontaneous urticaria in adults - Brazilian Society of Dermatology
por: Criado, Paulo Ricardo, et al.
Publicado: (2019) -
Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology()()
por: Ramos, Paulo Müller, et al.
Publicado: (2020) -
Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology()()
por: Bagatin, Ediléia, et al.
Publicado: (2020)